4-isobutylstyrene (current best: ∼95% yield, 91% ee) and
6-methoxy-2-vinylnaphthalene (73% yield; 86% ee), potential
precursors of antiinflammatory 2-arylpropionic acids, (S)-
ibuprofen and (S)-naproxen, the latter a hugely successful
commercial drug (Aleve) currently produced by classical
resolution.4 Since binaphthol-derived phosphoramidites5 were
introduced for asymmetric HV of vinylarenes,6a under our
originally reported conditions,2a these ligands have been used
with varying degree of success for HV of a variety of
substrates including norbornene,6b 1,3-dienes,6c and 1-sub-
stituted styrenes.6d,e Asymmetric HV of similar substrates is
the starting point for several total synthesis efforts (e.g.,
pseudopterosins and related compounds (see eq 1)) in our
group; therefore, we decided to explore the scope of ligand
tuning in this highly versatile, modular ligand system, and
the results are reported in this paper. Ligands L1-L10 (Figure
1), readily prepared7,8 from the corresponding bisphenols,
of all-carbon quaternary centers.6d The results are tabulated
in Table 1. A sample of the racemic compound was prepared
Table 1. Asymmetric Hydrovinylation of 4-Methoxystyrenea,b
ligand
(mol %)
conv
(%)
selec.
(%)
entry
% eec
confd
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
L1 + L2/0.7
L1/0.7
L2/0.7
L3/0.7
L4/0.7
L5/0.7
L5/2.0
L6/0.7
L6/2.0
L7/2.0
L8/0.7
L8/1.0
L8/2.0
L9/0.7
L9/1.0
L9/2.0
>99
>99
>99
>99
0
23
87
21
>99
14
2
2
21
73
>99
>99
>99
>99
>99
>99
>99
-
>99
>99
>99
95
>99
>99
>99
>99
>99
91
0
94
>95
94
-
76
78
90
92
16
86
85
87
91
88
87
98
-
S
R
S
-
S
S
S
S
S
S
S
S
S
S
S
S
65
>99
L
10/0.7
a
See Supporting Information for full experimental details. b Conversions
and selectivities determined by GC analysis. c GC on Cyclodex-B column.
d
Configuration assigned by comparison of GC retention times of known
compounds.3
in a reaction of p-methoxystyrene with ethylene (1 atm) in
the presence of a catalytic amount of [(allyl)NiBr]2, a racemic
ligand (a 1:1 mixture of L1 and L2), and sodium tetrakis-
[(3,5-trifluoromethyl)phenyl]borate [NaBARF] (Table 1,
entry 1).
Among the ligands examined, in addition to the original
Feringa ligand L3, two others stand out.8 The ligand L1 (or
its enantiomer L2), which has only a lowly biphenyl
backbone instead of a chiral binaphthyl unit and is signifi-
cantly cheaper, still yields similar selectivities and conver-
sions (entries 2 and 3). The ligand L10, in which the (S)-N-
R-methylbenzyl groups are replaced with achiral benzyl and
chiral (S)-R-methyl-1-naphthyl groups, is by far the best
ligand for this exacting reaction,9 yielding nearly quantitative
yield and selectivity (entry 17). Surprisingly, ligands prepared
from achiral dibenzylamine and enantiopure 2,2′-binaphthol
(not shown) gave no conversion.8
Figure 1. Selected phosphoramidite ligands.
PCl3, and various chiral amines, were used for this study.
The feasibility of ligand control in the hydrovinyl-
ation was initially investigated using p-methoxystyrene, an
electron-rich model substrate that consistently had given
one of the poorest reactions (80% yield, 73% ee)
among vinylarenes tested previously. We started
these investigations using a modified protocol (eq 1, R )
4-OMe) that had originally been developed for the generation
(3) Zhang, A.; RajanBabu, T. V. Org. Lett. 2004, 6, 1515.
(4) For a review of synthesis of 2-arylpropionic acids, see: Stahly, G.
P.; Starrett, R. M. In Chirality in Industry II; Collins, A. N., Sheldrake, G.
N., Crosby, J., Eds.; John Wiley: Chichester, 1997.
(5) (a) Feringa, B. L. Acc. Chem. Res. 2000, 33, 346. (b) Arnold, L. A.;
Imbos, R.; Mandoli, A.; de Vries, A. H. M.; Naasz, R.; Feringa, B. L.
Tetrahedron 2000, 56, 2865.
(6) (a) Francio´, G.; Faraone, F.; Leitner, W. J. Am. Chem. Soc. 2002,
124, 736. (b) Kumareswaran, R.; Nandi, N.; RajanBabu, T. V. Org. Lett.
2003, 5, 4345. (c) Zhang, A.; RajanBabu, T. V. J. Am. Chem. Soc. 2006,
128, 54. (d) Zhang, A: RajanBabu, T. V. J. Am. Chem. Soc. 2006, 128,
5620. (e) Shi, W.-J.; Zhang, Q.; Xie, J.-H.; Zhu, S.-F.; Hou, G.-H.; Zhou,
Q.-L. J. Am. Chem. Soc. 2006, 128, 2780.
(7) For representative examples of finely tuned phosphoramidites from
various research groups, see: (a) Alexakis, A.; Polet, D.; Rosset, S.; March,
S. J. Org. Chem. 2004, 69, 5660. (b) Bernsmann, H.; van den Berg, M.;
Hoen, R.; Minnaard, A. J.; Mehler, G.; Reetz, M. T.; De Vries, J. G.;
Feringa, B. L. J. Org. Chem. 2005, 70, 943. (c) Streiff, S.; Welter, C.;
Schelwies, M.; Lipowsky, G.; Miller, N.; Helmchen, G. Chem. Commun.
2005, 2957. (d) Leitner, A.; Shekhar, S.; Pouy, M. J.; Hartwig, J. F. J. Am.
Chem. Soc. 2005, 127, 15506. (e) Yu, R. T.; Rovis, T. J. Am. Chem. Soc.
2006, 128, 12370. (f) Du, H.; Yuan, W.; Zhao, B.; Shi, Y. J. Am. Chem.
Soc. 2007, 129, 11688.
Hydrovinylation of other vinylarenes, 1-alkylvinyl-
arenes, and an open-chain diene was attempted under
(9) To the best of our knowledge, this ligand has not been described in
the literature.
(10) For the best asymmetric routes to date, Naproxen via Ru-catalyzed
asymmetric hydrogenation of 2-arylacrylic acids: (a) Ohta, T.; Takaya, H.;
Kitamura, M; Nagai, K.; Noyori, R. J. Org. Chem. 1987, 52, 3174 (98%
ee). Ni-catalyzed asymmetric hydrocyanation: (b) RajanBabu, T. V.;
Casalnuovo, A. L. J. Am. Chem. Soc. 1996, 118, 6325 and references cited
therein (95% ee). Ibuprofen via Ru-catalyzed hydrogenation: (c) Uemura,
T.; Zhang, X.; Matsumura, K.; Sayo, N.; Kumobayashi, H.; Ohta, T.; Nozaki,
K.; Takaya, H. J. Org. Chem. 1996, 61, 5510 (97% ee). Rh-catalyzed
asymmetric hydroformylation: (d) Nozaki, K.; Sakai, N.; Nanno, T.;
Higashijima, T.; Mano, S.; Horiuchi, T.; Takaya, H. J. Am. Chem. Soc.
1997, 119, 4413 (92% ee). Hydrovinylation: ref 3 (91%). No useful catalytic
asymmetric methods are known for other (S)-2-arylpropionic acid precursors.
(8) See Supporting Information for experimental details and a more
complete list of ligands.
1658
Org. Lett., Vol. 10, No. 8, 2008